Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1958 28
1959 26
1960 29
1961 26
1962 50
1963 109
1964 119
1965 80
1966 64
1967 80
1968 75
1969 97
1970 98
1971 110
1972 123
1973 189
1974 245
1975 247
1976 202
1977 190
1978 211
1979 200
1980 224
1981 222
1982 250
1983 287
1984 315
1985 337
1986 342
1987 364
1988 370
1989 389
1990 428
1991 515
1992 526
1993 554
1994 575
1995 533
1996 556
1997 549
1998 588
1999 558
2000 665
2001 603
2002 609
2003 678
2004 710
2005 728
2006 865
2007 766
2008 821
2009 830
2010 856
2011 927
2012 895
2013 945
2014 1011
2015 994
2016 952
2017 952
2018 1029
2019 1049
2020 1255
2021 1506
2022 1326
2023 1196
2024 426

Text availability

Article attribute

Article type

Publication date

Search Results

31,370 results

Results by year

Filters applied: . Clear all
Page 1
Schwann Cell-Derived Exosomes and Methylprednisolone Composite Patch for Spinal Cord Injury Repair.
Zhu B, Gu G, Ren J, Song X, Li J, Wang C, Zhang W, Huo Y, Wang H, Jin L, Feng S, Wei Z. Zhu B, et al. ACS Nano. 2023 Nov 28;17(22):22928-22943. doi: 10.1021/acsnano.3c08046. Epub 2023 Nov 10. ACS Nano. 2023. PMID: 37948097
We designed a nanofiber scaffold hyaluronic acid hydrogel patch to release both exosomes and methylprednisolone to the injured spinal cord in a non-invasive manner. ...
We designed a nanofiber scaffold hyaluronic acid hydrogel patch to release both exosomes and methylprednisolone to the injured spinal …
Depo-Medrol.
Woodhouse D. Woodhouse D. Med J Aust. 1992 Jan 20;156(2):139. Med J Aust. 1992. PMID: 1736063 No abstract available.
From the editor.
Novick LF. Novick LF. J Public Health Manag Pract. 2013 Jul-Aug;19(4):285. doi: 10.1097/PHH.0b013e318294f799. J Public Health Manag Pract. 2013. PMID: 23719388 No abstract available.
Methylprednisolone aceponate for atopic dermatitis.
Torrelo A. Torrelo A. Int J Dermatol. 2017 Jun;56(6):691-697. doi: 10.1111/ijd.13485. Epub 2017 Mar 4. Int J Dermatol. 2017. PMID: 28258632 Review.
BACKGROUND: The 4th generation topical corticosteroids (TCS) have demonstrated a most favorablerisk-benefit ratio. Methylprednisolone aceponate (MPA) is a non-halogenated corticosteroid with a methyl group at C6, which confers higher intrinsic activity. ...
BACKGROUND: The 4th generation topical corticosteroids (TCS) have demonstrated a most favorablerisk-benefit ratio. Methylprednisolone
The big shot.
[No authors listed] [No authors listed] Lancet. 1977 Mar 19;1(8012):633-4. Lancet. 1977. PMID: 66434 No abstract available.
[Methylprednisolone- acute spinal cord injury, benefits or risks?].
Tęsiorowski M, Potaczek T, Jasiewicz B, Sapa J, Zygmunt M. Tęsiorowski M, et al. Postepy Hig Med Dosw (Online). 2013 Jun 26;67:601-9. doi: 10.5604/17322693.1054873. Postepy Hig Med Dosw (Online). 2013. PMID: 23800640 Free article. Review. Polish.
Its mechanism of action of methylprednisolone is the result of many cellular changes. Methylprednisolone is used in many diseases, such as rheumatic diseases, autoimmune diseases, allergic, anaphylactic shock, asthma. Methylprednisolone was also used in patie …
Its mechanism of action of methylprednisolone is the result of many cellular changes. Methylprednisolone is used in many disea …
[Pharmacological therapies for ARDS].
Izumida H, Fujishima S. Izumida H, et al. Masui. 2013 May;62(5):541-6. Masui. 2013. PMID: 23772527 Review. Japanese.
Available evidence is against early administration of high-dose corticosteroids (methylprednisolon 120 mg x kg-1 x day - 1). In contrast, low-dose corticosteroid therapy (methylprednisolon 0.5-2.5mgg kg-1 xday-1)remains controversial. ...
Available evidence is against early administration of high-dose corticosteroids (methylprednisolon 120 mg x kg-1 x day - 1). In contr …
Sinonasal sarcoid.
Bakshi J, Venables PJ, Abraham S. Bakshi J, et al. J Postgrad Med. 2009 Jan-Mar;55(1):43-4. doi: 10.4103/0022-3859.48441. J Postgrad Med. 2009. PMID: 19242080 No abstract available.
31,370 results
You have reached the last available page of results. Please see the User Guide for more information.